The times mentioned in the scientific program below are in the Istanbul time zone and refer to the time zone of GMT+3.
Please select from the list below the time zone you’d like to see the program times in.

Istanbul Time Zone, UTC+3
12 December 2020 Saturday
09:00-09:26 Opening Ceremony
09:00-09:05 Welcome Speech Dr. John Davis
09:05-09:10 Welcome Speech Dr. M. Derya Balbay
09:10-09:13 Opening speech: History of IPF Dr. Atif Akdas
09:13-09:26 Opening speech: History of IPF Dr. Hiroki Watanabe
09:26-12:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
09:26-09:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
09:42-09:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
09:55-10:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
10:11-10:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
10:22-10:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
10:35-10:50 Break
10:50-11:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
11:09-11:26 Imaging Cases Dr. Samir Taneja
11:26-11:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
11:38-11:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
11:56-12:13 PET Imaging: new agents coming?  Dr. Phillip Koo
12:13-12:40 Session 1-Questions and Answers (*)  
12:40-13:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
13:40-17:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
13:40-13:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
13:54-14:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
14:16-14:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
14:30-14:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
14:50-15:05 Break
15:05-15:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
15:12-15:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
15:29-15:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
15:40-15:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
15:53-16:10 Break
16:10-16:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
16:30-16:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
16:43-16:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
16:54-17:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
17:12-17:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
09:30-11:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
09:30-09:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
09:45-10:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
10:05-10:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
10:20-10:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
10:35-10:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
10:49-11:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
11:04-11:30 Session 3-Questions and Answers  
11:30-11:45 Break
11:45-13:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
11:45-12:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
12:05-12:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
12:47-13:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
13:10-13:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
13:30-13:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
13:50-14:30 Lunch Break
14:30-17:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
17:00-17:10 Closing remarks Dr. Erdem Canda
New York Time Zone, UTC-5
12 December 2020 Saturday
01:00-01:26 Opening Ceremony
01:00-01:05 Welcome Speech Dr. John Davis
01:05-01:10 Welcome Speech Dr. M. Derya Balbay
01:10-01:13 Opening speech: History of IPF Dr. Atif Akdas
01:13-01:26 Opening speech: History of IPF Dr. Hiroki Watanabe
01:26-04:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
01:26-01:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
01:42-01:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
01:55-02:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
02:11-02:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
02:22-02:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
02:35-02:50 Break
02:50-03:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
03:09-03:26 Imaging Cases Dr. Samir Taneja
03:26-03:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
03:38-03:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
03:56-04:13 PET Imaging: new agents coming?  Dr. Phillip Koo
04:13-04:40 Session 1-Questions and Answers (*)  
04:40-05:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
05:40-09:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
05:40-05:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
05:54-06:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
06:16-06:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
06:30-06:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
06:50-07:05 Break
07:05-07:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
07:12-07:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
07:29-07:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
07:40-07:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
07:53-08:10 Break
08:10-08:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
08:30-08:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
08:43-08:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
08:54-09:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
09:12-09:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
01:30-03:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
01:30-01:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
01:45-02:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
02:05-02:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
02:20-02:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
02:35-02:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
02:49-03:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
03:04-03:30 Session 3-Questions and Answers  
03:30-03:45 Break
03:45-05:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
03:45-04:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
04:05-04:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
04:47-05:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
05:10-05:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
05:30-05:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
05:50-06:30 Lunch Break
06:30-09:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
09:00-09:10 Closing remarks Dr. Erdem Canda
Berlin Time Zone, UTC+1
12 December 2020 Saturday
07:00-07:26 Opening Ceremony
07:00-07:05 Welcome Speech Dr. John Davis
07:05-07:10 Welcome Speech Dr. M. Derya Balbay
07:10-07:13 Opening speech: History of IPF Dr. Atif Akdas
07:13-07:26 Opening speech: History of IPF Dr. Hiroki Watanabe
07:26-10:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
07:26-07:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
07:42-07:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
07:55-08:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
08:11-08:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
08:22-08:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
08:35-08:50 Break
08:50-09:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
09:09-09:26 Imaging Cases Dr. Samir Taneja
09:26-09:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
09:38-09:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
09:56-10:13 PET Imaging: new agents coming?  Dr. Phillip Koo
10:13-10:40 Session 1-Questions and Answers (*)  
10:40-11:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
11:40-15:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
11:40-11:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
11:54-12:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
12:16-12:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
12:30-12:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
12:50-13:05 Break
13:05-13:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
13:12-13:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
13:29-13:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
13:40-13:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
13:53-14:10 Break
14:10-14:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
14:30-14:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
14:43-14:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
14:54-15:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
15:12-15:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
07:30-09:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
07:30-07:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
07:45-08:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
08:05-08:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
08:20-08:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
08:35-08:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
08:49-09:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
09:04-09:30 Session 3-Questions and Answers  
09:30-09:45 Break
09:45-11:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
09:45-10:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
10:05-10:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
10:47-11:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
11:10-11:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
11:30-11:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
11:50-12:30 Lunch Break
12:30-15:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
15:00-15:10 Closing remarks Dr. Erdem Canda
Tokyo Time Zone, UTC+9
12 December 2020 Saturday
15:00-15:26 Opening Ceremony
15:00-15:05 Welcome Speech Dr. John Davis
15:05-15:10 Welcome Speech Dr. M. Derya Balbay
15:10-15:13 Opening speech: History of IPF Dr. Atif Akdas
15:13-15:26 Opening speech: History of IPF Dr. Hiroki Watanabe
15:26-18:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
15:26-15:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
15:42-15:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
15:55-16:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
16:11-16:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
16:22-16:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
16:35-16:50 Break
16:50-17:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
17:09-17:26 Imaging Cases Dr. Samir Taneja
17:26-17:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
17:38-17:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
17:56-18:13 PET Imaging: new agents coming?  Dr. Phillip Koo
18:13-18:40 Session 1-Questions and Answers (*)  
18:40-19:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
19:40-23:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
19:40-19:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
19:54-20:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
20:16-20:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
20:30-20:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
20:50-21:05 Break
21:05-21:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
21:12-21:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
21:29-21:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
21:40-21:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
21:53-22:10 Break
22:10-22:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
22:30-22:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
22:43-22:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
22:54-23:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
23:12-23:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
15:30-17:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
15:30-15:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
15:45-16:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
16:05-16:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
16:20-16:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
16:35-16:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
16:49-17:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
17:04-17:30 Session 3-Questions and Answers  
17:30-17:45 Break
17:45-19:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
17:45-18:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
18:05-18:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
18:47-19:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
19:10-19:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
19:30-19:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
19:50-20:30 Lunch Break
20:30-23:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
23:00-23:10 Closing remarks Dr. Erdem Canda

(*) If you have a question for the presenter, you can write it in the “Questions and Answers” section, which you will find on the “Meeting Room” page. The questions are to be addressed by the speakers during the “Questions and Answers” period at the end of each session.